ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Keenova Therapeutics plc clinical trials

Also known as Mallinckrodt, MNK.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 247 studies whose lead sponsor is Keenova Therapeutics plc or one of 11 companies grouped under it. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 16, 2026.

Our grouping of 12 registry names, not the registry’s. See them and correct one ↓

Pipeline: 1 program

Each counted once: 1 with a study Keenova Therapeutics plc leads registered in the last two years.

  • Phase 4 (approved, new studies)

The 1 program — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Keenova Therapeutics plc’s own registered studies; Keenova Therapeutics plc’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Keenova Therapeutics plc’s studies test, most open studies first — 40 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 40; every drug is on its own page, and each page lists its sponsors.

What changed recently

From the registry's own updates since Oct 19, 2026.

All 247 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now21%
  • Completed18776%
  • Stopped early5522%Terminated 46 · Withdrawn 8 · Suspended 1
  • Status unknown or other31%No longer available 2 · Approved for marketing 1

Phase

  • Phase 399
  • Phase 272
  • Phase 135
  • Phase 427
  • Early Phase 11

Where

  • United States202
  • Canada18
  • United Kingdom17
  • Germany16
  • Australia15
  • Belgium13

Over the years

  1. 2607
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 226

By the year each study started; 70 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Keenova Therapeutics plc.

  • Endo Pharmaceuticals
    Acquired — became part of Keenova Therapeutics plc, Jul 31, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    99 studies →
  • Mallinckrodt
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    87 studies
  • Sucampo Pharma Americas, LLC
    Acquired — became part of Keenova Therapeutics plc, Feb 13, 2018 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    17 studies →
  • Stratatech, a Mallinckrodt Company
    Acquired — became part of Keenova Therapeutics plc, Aug 31, 2016 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    9 studies →
  • Endo USA Inc., a Keenova Therapeutics Company
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    8 studies →
  • InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company
    Acquired — became part of Keenova Therapeutics plc, Sep 25, 2017 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    8 studies →
  • Ocera Therapeutics
    Acquired — became part of Keenova Therapeutics plc, Dec 11, 2017 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    7 studies →
  • Ocera Therapeutics, Inc.
    Acquired — became part of Keenova Therapeutics plc, Dec 11, 2017 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Mallinckrodt ARD LLC
    Acquired — became part of Keenova Therapeutics plc, Aug 14, 2014 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • R-Tech Ueno, Ltd.
    Acquired — became part of Keenova Therapeutics plc, Feb 13, 2018 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Cadence Pharmaceuticals
    Acquired — became part of Keenova Therapeutics plc, Mar 19, 2014 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company
    Acquired — became part of Keenova Therapeutics plc, Feb 13, 2018 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →

Focus areas

Conditions Keenova Therapeutics plc leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 247. Browse all 247 →